R. Michael Carruthers - 17 Jun 2022 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Tammy Furlong, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
17 Jun 2022
Transactions value $
$0
Form type
4
Filing time
22 Jun 2022, 18:41:03 UTC
Previous filing
25 May 2022
Next filing
10 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Stock Option (Right to Buy) Award $0 +15.6K $0.00 15.6K 17 Jun 2022 Common Stock 15.6K $1.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 100% of the total shares on the one year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date.